This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reisbig, M. D.
Right arrow Articles by Hanson, N. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reisbig, M. D.
Right arrow Articles by Hanson, N. D.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, November 2004, p. 4177-4182, Vol. 48, No. 11
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.11.4177-4182.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Promoter Sequences Necessary for High-Level Expression of the Plasmid-Associated ampC ß-Lactamase Gene blaMIR-1

Mark D. Reisbig and Nancy D. Hanson*

Department of Medical Microbiology and Immunology, Center for Research in Anti-Infectives and Biotechnology, Creighton University School of Medicine, Omaha, Nebraska

Received 9 February 2004/ Returned for modification 23 April 2004/ Accepted 26 June 2004

Little is known about mechanisms involved in high-level expression of plasmid-associated ampC genes. The sequence for blaMIR-1 has been elucidated, and the gene is not inducible. Although the sequence for the promoter (prA) that drives expression of Enterobacter cloacae chromosomal ampC is present upstream of blaMIR-1, high-level expression from blaMIR-1 is directed from a hybrid promoter (prB) located further upstream of prA. The purpose of this study was to determine the influence of each promoter on blaMIR-1 expression and ß-lactam resistance. RNA expression by deletion clones with both promoters was measured and compared to that by clones in which –35 and/or –10 elements of prA and/or prB were altered. Primer extension revealed two start sites for blaMIR-1 transcription. Expression of blaMIR-1 in clones with both promoters was 171-fold higher than that in clones carrying only prA. In addition, blaMIR-1 expression from prA increased 11-fold in the presence of the prB –10 element compared to expression driven from prA alone. Ceftazidime and cefotaxime MICs increased 42- and 64-fold, respectively, for the clone expressing blaMIR-1 from both promoters compared to expression from prA alone. The upstream promoter prB of blaMIR-1 is solely responsible for high-level expression required for cefotaxime and ceftazidime resistance. These data suggest that resistance to extended-spectrum cephalosporins mediated by noninducible plasmid-associated ampC genes requires the formation of novel promoter elements that are capable of increasing ampC expression.

* Corresponding author. Mailing address: Center for Research in Anti-Infectives and Biotechnology, Department of Microbiology and Immunology, Creighton University School of Medicine, 2500 California Pl., Omaha, NE 68178. Phone: (402) 280-5837. Fax: (402) 280-1875. E-mail: ndhanson{at}creighton.edu.

Antimicrobial Agents and Chemotherapy, November 2004, p. 4177-4182, Vol. 48, No. 11
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.11.4177-4182.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Jacoby, G. A. (2009). AmpC {beta}-Lactamases. Clin. Microbiol. Rev. 22: 161-182 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»